AAIC 2024 Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
AAIC 2024 Insights: Potential of Targeting the Alpha-1 Adrenergic Receptor and Phosphoglycerate Kinase 1 With Terazosin to Treat Alzheimer’s Disease Using a Transgenic Rat Model
By
AAIC 2024 Insights Hub
FEATURING
Swastik G. Pattanashetty
By
AAIC 2024 Insights Hub
FEATURING
Swastik G. Pattanashetty
Comments 0
Login to view comments.
Click here to Login